NS · Pharmaceuticals

Bliss GVS Pharma Ltd (BLISSGVS)

Pharmaceuticals & Biotechnology

Bliss GVS Pharma Ltd (BLISSGVS) is listed on NS in the Pharmaceuticals sector. Industry: Pharmaceuticals & Biotechnology. As of 2026-07-10, reported market cap is $49.67B, P/E ratio is 51.26, net margin is 10.1%, dividend yield is 0.11%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Download on the App Store Get it on Google Play

Key metrics for BLISSGVS

Market cap

$49.67B

P/E ratio

51.26

Net margin

10.1%

Dividend yield

0.11%

Bliss GVS Pharma Ltd (BLISSGVS) — FAQ

What is Bliss GVS Pharma Ltd's market cap?

Bliss GVS Pharma Ltd (BLISSGVS) has a reported market cap of $49.67B (data as of 2026-07-10).

What is BLISSGVS's P/E ratio?

The price-to-earnings (P/E) ratio for Bliss GVS Pharma Ltd (BLISSGVS) is 51.26 (data as of 2026-07-10).

Does Bliss GVS Pharma Ltd pay a dividend?

Bliss GVS Pharma Ltd (BLISSGVS) shows a reported dividend yield of 0.11%. Open the MyAverix Finance app for dividend history and payout details (data as of 2026-07-10).

What sector is Bliss GVS Pharma Ltd in?

Bliss GVS Pharma Ltd (BLISSGVS) is classified in the Pharmaceuticals sector (Pharmaceuticals & Biotechnology industry).

What exchange is BLISSGVS listed on?

BLISSGVS is listed on NS.

What is Bliss GVS Pharma Ltd's net margin?

Bliss GVS Pharma Ltd (BLISSGVS) reports a net margin of 10.1% (data as of 2026-07-10).

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Pharmaceuticals companies

FDC Ltd (FDC) Strides Pharma Science Ltd (STAR)